BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 7, Issue 4
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial
©The Author(s) 2019.
World J Clin Cases. Feb 26, 2019; 7(4): 452-465
Published online Feb 26, 2019. doi: 10.12998/wjcc.v7.i4.452
Table 5 Adverse events % (n)
1.2 L PEG-ASCPEG-ELSP value
Nausea6.1 (9)12.6 (18)0.087
Vomiting0.7 (1)2.8 (4)0.34
Abdominal discomfort9.5 (14)7.7 (11)0.59
Abdominal pain2.7 (4)3.5 (5)0.96
Dizziness0 (0)2.1 (3)0.23
Chill1.4 (2)2.1 (3)0.97
No discomfort81.8 (120)76.2 (109)0.31
PEG-ASC: Polyethylene glycol plus ascorbic acid; PEG-ELS: Polyethylene glycol-based electrolyte solution.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.